SCHEMBL17047745

SCHEMBL17047745

CC1=C(C)C(=O)N(c2ccsc2)C1=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.40
PARP15 Q460N3 1/20 0.40
PARP10 Q53GL7 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.37
HCAR1 Q9BXC0 1/20 0.36
MAPT P10636 5/20 0.35
MEN1 O00255 5/20 0.35
KMT2A Q03164 5/20 0.35
PKM P14618 3/20 0.35
HPGD P15428 1/20 0.35
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
ALDH1A1 P00352 4/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
KDM4A O75164 1/20 0.33
HSD17B10 Q99714 1/20 0.33
KDM4C Q9H3R0 1/20 0.33
MAPK1 P28482 1/20 0.32
IDH1 O75874 1/20 0.32
KDM4E B2RXH2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21478341 0.82 MEN1 (0.38) HCAR1MAPTMEN1KMT2APKM
SCHEMBL8980795 0.78 KMT2A (0.50) MEN1KMT2ARAB9AHTT
SCHEMBL28090496 0.74 MGLL (0.54) PKMALDH1A1MAPK1
SCHEMBL15849078 0.69 ELANE (0.65) MAPTMEN1KMT2AHPGDNPC1
3,4-Dimethylphenylmaleimide SCHEMBL5074358 0.69 PARP1 (0.53) PARP1PARP15PARP10SMN1; SMN2MAPT
SCHEMBL915633 0.67 CES1 (0.64) ALDH1A1CES2CES1
SCHEMBL27695461 0.66 LCK (0.39) SMN1; SMN2MAPTALDH1A1HSD17B10KDM4E
SCHEMBL10799063 0.65 F2 (0.43) PARP1PARP15PARP10SMN1; SMN2MEN1
SCHEMBL142041 0.65 MGLL (0.56) PARP1PARP15PARP10SMN1; SMN2MAPT
SCHEMBL11443380 0.65 APAF1 (0.61) PARP1PARP15PARP10SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3110808-B1 PLANT GROWTH REGULATING COMPOUNDS SYNGENTA PARTICIPATIONS AG (CH) 2018-08-29 EP disclosed
US-9751867-B2 Plant growth regulating compounds SYNGENTA PARTICIPATIONS AG (CH) 2017-09-05 US disclosed
EP-3110808-A1 PLANT GROWTH REGULATING COMPOUNDS Syngenta Participations AG (CH) 2017-01-04 EP disclosed
US-20160368900-A1 PLANT GROWTH REGULATING COMPOUNDS SYNGENTA PARTICIPATIONS AG (CH) 2016-12-22 US disclosed
WO-2015128321-A1 PLANT GROWTH REGULATING COMPOUNDS SYNGENTA PARTICIPATIONS AG (CH) 2015-09-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160368900-A1 PLANT GROWTH REGULATING COMPOUNDS GHDC, GAK, EIF4G2 PARP1 4358/4885PARP15 3140/4885PARP10 3839/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.